353 related articles for article (PubMed ID: 24760868)
1. Activity-dependent tau protein translocation to excitatory synapse is disrupted by exposure to amyloid-beta oligomers.
Frandemiche ML; De Seranno S; Rush T; Borel E; Elie A; Arnal I; Lanté F; Buisson A
J Neurosci; 2014 Apr; 34(17):6084-97. PubMed ID: 24760868
[TBL] [Abstract][Full Text] [Related]
2. Synaptotoxicity in Alzheimer's Disease Involved a Dysregulation of Actin Cytoskeleton Dynamics through Cofilin 1 Phosphorylation.
Rush T; Martinez-Hernandez J; Dollmeyer M; Frandemiche ML; Borel E; Boisseau S; Jacquier-Sarlin M; Buisson A
J Neurosci; 2018 Nov; 38(48):10349-10361. PubMed ID: 30341179
[TBL] [Abstract][Full Text] [Related]
3. Tau phosphorylation and tau mislocalization mediate soluble Aβ oligomer-induced AMPA glutamate receptor signaling deficits.
Miller EC; Teravskis PJ; Dummer BW; Zhao X; Huganir RL; Liao D
Eur J Neurosci; 2014 Apr; 39(7):1214-24. PubMed ID: 24713000
[TBL] [Abstract][Full Text] [Related]
4. Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines.
Zempel H; Thies E; Mandelkow E; Mandelkow EM
J Neurosci; 2010 Sep; 30(36):11938-50. PubMed ID: 20826658
[TBL] [Abstract][Full Text] [Related]
5. Effect of Aβ Oligomers on Neuronal APP Triggers a Vicious Cycle Leading to the Propagation of Synaptic Plasticity Alterations to Healthy Neurons.
Rolland M; Powell R; Jacquier-Sarlin M; Boisseau S; Reynaud-Dulaurier R; Martinez-Hernandez J; André L; Borel E; Buisson A; Lanté F
J Neurosci; 2020 Jul; 40(27):5161-5176. PubMed ID: 32444385
[TBL] [Abstract][Full Text] [Related]
6. Linking amyloid-β and tau: amyloid-β induced synaptic dysfunction via local wreckage of the neuronal cytoskeleton.
Zempel H; Mandelkow EM
Neurodegener Dis; 2012; 10(1-4):64-72. PubMed ID: 22156588
[TBL] [Abstract][Full Text] [Related]
7. A critical role for the PAR-1/MARK-tau axis in mediating the toxic effects of Aβ on synapses and dendritic spines.
Yu W; Polepalli J; Wagh D; Rajadas J; Malenka R; Lu B
Hum Mol Genet; 2012 Mar; 21(6):1384-90. PubMed ID: 22156579
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous Association of Alzheimer's Disease-Linked Amyloid-β and Amyloid-β Protein Precursor with Synapses.
Willén K; Sroka A; Takahashi RH; Gouras GK
J Alzheimers Dis; 2017; 60(2):511-524. PubMed ID: 28869466
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-β(1-40) inhibits amyloid-β(1-42) induced activation of cytoplasmic phospholipase A2 and synapse degeneration.
Bate C; Williams A
J Alzheimers Dis; 2010; 21(3):985-93. PubMed ID: 20634578
[TBL] [Abstract][Full Text] [Related]
10. Long-term depression links amyloid-β to the pathological hyperphosphorylation of tau.
Taylor HBC; Emptage NJ; Jeans AF
Cell Rep; 2021 Aug; 36(9):109638. PubMed ID: 34469725
[TBL] [Abstract][Full Text] [Related]
11. Synaptic targeting by Alzheimer's-related amyloid beta oligomers.
Lacor PN; Buniel MC; Chang L; Fernandez SJ; Gong Y; Viola KL; Lambert MP; Velasco PT; Bigio EH; Finch CE; Krafft GA; Klein WL
J Neurosci; 2004 Nov; 24(45):10191-200. PubMed ID: 15537891
[TBL] [Abstract][Full Text] [Related]
12. Leptin prevents hippocampal synaptic disruption and neuronal cell death induced by amyloid β.
Doherty GH; Beccano-Kelly D; Yan SD; Gunn-Moore FJ; Harvey J
Neurobiol Aging; 2013 Jan; 34(1):226-37. PubMed ID: 22921154
[TBL] [Abstract][Full Text] [Related]
13. Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins.
Pham E; Crews L; Ubhi K; Hansen L; Adame A; Cartier A; Salmon D; Galasko D; Michael S; Savas JN; Yates JR; Glabe C; Masliah E
FEBS J; 2010 Jul; 277(14):3051-67. PubMed ID: 20573181
[TBL] [Abstract][Full Text] [Related]
14. The Ca(2+) channel inhibitor 2-APB reverses β-amyloid-induced LTP deficit in hippocampus by blocking BAX and caspase-3 hyperactivation.
Hu WY; He ZY; Yang LJ; Zhang M; Xing D; Xiao ZC
Br J Pharmacol; 2015 May; 172(9):2273-85. PubMed ID: 25521332
[TBL] [Abstract][Full Text] [Related]
15. Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures.
Zheng WH; Bastianetto S; Mennicken F; Ma W; Kar S
Neuroscience; 2002; 115(1):201-11. PubMed ID: 12401334
[TBL] [Abstract][Full Text] [Related]
16. Tau and Amyloid β Protein in Patient-Derived Aqueous Brain Extracts Act Concomitantly to Disrupt Long-Term Potentiation
Ondrejcak T; Klyubin I; Hu NW; O'Malley TT; Corbett GT; Winters R; Perkinton MS; Billinton A; Prenderville JA; Walsh DM; Rowan MJ
J Neurosci; 2023 Aug; 43(32):5870-5879. PubMed ID: 37491315
[TBL] [Abstract][Full Text] [Related]
17. Dendritic Tau in Alzheimer's Disease.
Ittner A; Ittner LM
Neuron; 2018 Jul; 99(1):13-27. PubMed ID: 30001506
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the Motor Protein Eg5/Kinesin-5 in Amyloid β-Mediated Impairment of Hippocampal Long-Term Potentiation and Dendritic Spine Loss.
Freund RK; Gibson ES; Potter H; Dell'Acqua ML
Mol Pharmacol; 2016 May; 89(5):552-9. PubMed ID: 26957206
[TBL] [Abstract][Full Text] [Related]
19. WASP-1, a canonical Wnt signaling potentiator, rescues hippocampal synaptic impairments induced by Aβ oligomers.
Vargas JY; Ahumada J; Arrázola MS; Fuenzalida M; Inestrosa NC
Exp Neurol; 2015 Feb; 264():14-25. PubMed ID: 25450465
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone prevents amyloid-β oligomer-induced impairment of synapse formation and plasticity via increasing dendrite and spine mitochondrial number.
Xu S; Liu G; Bao X; Wu J; Li S; Zheng B; Anwyl R; Wang Q
J Alzheimers Dis; 2014; 39(2):239-51. PubMed ID: 24150104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
